The resolution comes after plaintiffs were unable to prove that J&J’s talc products caused their ovarian cancer ...

For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting ...

Trixeo/Breztri, is approved in the US for treatment of asthma, with regulatory filings currently under review in other major ...

A supplemental New Drug Application (sNDA) for Pfizer’s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) has ...

Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...

The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than ...

Takeda has announced new data from the two pivotal phase 3 studies of zasocitinib (TAK-279) in adults with moderate-to-severe ...

Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has appointed Hitesh ...

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with ...